1 Pantoni L. Cerebral small vessel disease：from

pathogenesis and clinical characteristics to therapeutic

challenges[J]. Lancet Neurol，2010，9：689-701.

2 Wardlaw JM，Smith C，Dichgans M. Mechanisms of

sporadic cerebral small vessel disease：insights from

neuroimaging[J]. Lancet Neurol，2013，12：483-497.

3 Joutel A，Faraci FM. Cerebral small vessel disease：

insights and opportunities from mouse models of

collagen IV-related small vessel disease and cerebral

autosomal dominant arteriopathy with subcortical

infarcts and leukoencephalopathy[J]. Stroke，2014，45：

1215-1221.

4 De Silva TM，Miller AA. Cerebral small vessel

disease：target ing oxidative st ress as a novel

therapeutic strategy?[J]. Front Pharmacol，2016，7：61.

5 Hachinski V. World Stroke Day 2008："little strokes，

big trouble"[J]. Stroke，2008，39：2407-2420.

6 Thompson CS，Hakim AM. Living beyond our

physiological means：small vessel disease of the brain

is an expression of a systemic failure in arteriolar

function：a unifying hypothesis[J]. Stroke，2009，40：

e322-330.

7 Craggs LJ，Yamamoto Y，Deramecourt V，et al.

Microvascular pathology and morphometrics of

sporadic and hereditary small vessel diseases of the

brain[J]. Brain Pathol，2014，24：495-509.

8 LADIS Study Group. 2001-2011：adecade of the

LADIS (Leukoaraiosis And DISability) Study：what

have we learned about white matter changes and

small-vessel disease?[J]. Cerebrovasc Dis，2011，32：

577-588.

9 Attwell D，Buchan AM，Charpak S，et al. Glial and

neuronal control of brain blood flow[J]. Nature，2010，

468：232-243.

10 De Silva TM，Faraci FM. Microvascular dysfunction

and cognitive impairment[J]. Cell Mol Neurobiol，

2016，36：241-258.

11 Fisher CM. Lacunes：small，deep cerebral infarcts[J].

Neurology，1965，15：774-784.

12 Fisher CM. Lacunar strokes and infarcts：a review[J].

Neurology，1982，32：871-876.

13 Fisher CM. Lacunar infarcts-a review[J]. Cerebrovasc

Dis，1991，1：311-320.

14 Mead GE，Lewis SC，Wardlaw JM，et al. Severe

ipsilateral carotid stenosis and middle cerebral

artery disease in lacunar ischaemic stroke：innocent

bystanders?[J]. J Neurol，2002，249：266-271.

15 J a c k s o n CA，Hut ch i son A，Den n is MS，e t

al. Dif fer ing r isk factor prof iles of ischemic

stroke subtypes：evidence for a distinct lacunar

arteriopathy?[J]. Stroke，2010，41：624-629.

16 Potter GM，Doubal FN，Jackson CA，et al. Lack of

association of white matter lesions with ipsilateral

carotid artery stenosis[J]. Cerebrovasc Dis，2012，33：

378-384.

17 Macdonald RL，Kowalczuk A，Johns L. Emboli enter

penetrating arteries of monkey brain in relation to

their size[J]. Stroke，1995，26：1247-1250；discussion

1250-1251.

18 Bailey EL，McCulloch J，Sudlow C，et al. Potential

animal models of lacunar stroke：a systematic

review[J]. Stroke，2009，40：e451-458.

19 Pantoni L，Garcia JH，Gutierrez JA. Cerebral white

matter is highly vulnerable to ischemia[J]. Stroke，

1996，27：1641-1646；discussion 1647.

20 Petito CK，Olarte JP，Roberts B，et al. Selective glial

vulnerability following transient global ischemia in

rat brain[J]. J Neuropathol Exp Neurol，1998，57：231-

238.

21 Brun A，Englund E. A white matter disorder in

中国卒中杂志 2017年２月 第12卷 第２期 139

dementia of the Alzheimer type：a pathoanatomical

study[J]. Ann Neurol，1986，19：253-262.

22 Millikan C，Futrell N. The fallacy of the lacune

hypothesis[J]. Stroke，1990，21：1251-1257.

23 Boiten J，Lodder J. Lacunar infarcts. Pathogenesis

and validity of the clinical syndromes[J]. Stroke，1991，

22：1374-1378.

24 Lee HY，Oh BH. Aging and arterial stiffness[J]. Circ J，

2010，74：2257-2262.

25 Poels MM，Zaccai K，Verwoert GC，et al. Arterial

stiffness and cerebral small vessel disease：the

Rotterdam Scan Study[J]. Stroke，2012，43：2637-2642.

26 Caplan LR，Hennerici M. Impaired clearance of

emboli (washout) is an important link between

hypoperfusion，embolism，and ischemic stroke[J].

Arch Neurol，1998，55：1475-1482.

27 Diehl RR. Cerebral autoregulation studies in clinical

practice[J]. Eur J Ultrasound，2002，16：31-36.

28 Silberberg DH，Manning MC，Schreiber AD. Tissue

culture demyelination by normal human serum[J].

Ann Neurol，1984，15：575-580.

29 Lammie GA，Brannan F，Wardlaw JM. Incomplete

lacunar infarct ion (Type I b lacunes)[J]. Acta

Neuropathol，1998，96：163-171.

30 Schley D，Carare-Nnadi R，Please CP，e t a l.

Mechanisms to explain the reverse perivascular

transport of solutes out of the brain[J]. J Theor Biol，

2006，238：962-974.

31 Weller RO，Djuanda E，Yow HY，et al. Lymphatic

drainage of the brain and the pathophysiology of

neurological disease[J]. Acta Neuropathol，2009，117：

1-14.

32 Wardlaw JM，Sandercock PA，Dennis MS，et al. Is

breakdown of the blood-brain barrier responsible

for lacunar stroke，leukoaraiosis，and dementia?[J].

Stroke，2003，34：806-812.

33 Ha i n swo r t h AH，Oommen AT，Br id ge s LR.

Endothelial cells and human cerebral small vessel

disease[J]. Brain Pathol，2015，25：44-50.

34 Wardlaw JM，Doubal F，Armitage P，et al. Lacunar

stroke is associated with diffuse blood-brain barrier

dysfunction[J]. Ann Neurol，2009，65：194-202.

35 Topakian R，Barrick TR，Howe FA，et al. Bloodbrain

barrier permeability is increased in normalappearing

white matter in patients with lacunar stroke

and leucoaraiosis[J]. J Neurol Neurosurg Psychiatry，

2010，81：192-197.

36 Tomimoto H，Akiguchi I，Suenaga T，e t a l .

Alterations of the blood-brain barrier and glial

cells in white-matter lesions in cerebrovascular and

Alzheimer's disease patients[J]. Stroke，1996，27：

2069-2074.

37 Utter S，Tamboli IY，Walter J，et al. Cerebral small

vessel disease-induced apolipoprotein E leakage

is associated with Alzheimer disease and the

accumulation of amyloid beta-protein in perivascular

astrocytes[J]. J Neuropathol Exp Neurol，2008，67：

842-856.

38 Young VG，Halliday GM，Kril JJ. Neuropathologic

cor relates of white mat ter hyper intensities[J].

Neurology，2008，71：804-811.

39 Vigga r s AP，Whar ton SB，Simpson JE，et al.

Alterations in the blood brain barrier in ageing

cerebral cortex in relationship to Alzheimer-type

pathology：a study in the MRC-CFAS population

neuropathology cohort[J]. Neurosci Lett，2011，505：

25-30.

40 Heye AK，Thrippleton MJ，Chappell FM，et al. Blood

pressure and sodium：Association with MRI markers

in cerebral small vessel disease[J]. J Cereb Blood

Flow Metab，2016，36：264-274.

41 FredrikssonK，Nordborg C，Kalimo H，et al. Cerebral

microangiopathy in stroke-prone spontaneously

hypertensive rats. An immunohistochemical and

ultrastructural study[J]. Acta Neuropathol，1988，75：

241-252.

42 Lin JX，Tomimoto H，Akiguchi I，et al. White matter

lesions and alteration of vascular cell composition

in the brain of spontaneously hypertensive rats[J].

Neuroreport，2001，12：1835-1839.

43 Ba i l e y EL，Wa r d l aw JM，Gr aham D，e t a l .

Cerebral small vessel endothel ial st ructural

changes predate hyper tension in st roke-prone

spontaneously hypertensive rats：a blinded，controlled

immunohistochemical study of 5- to 21-week-old

rats[J]. Neuropathol Appl Neurobiol，2011，37：711-726.

44 Ba i l e y EL，McBr ide MW，Beat t ie W，e t a l .

Differential gene expression in multiple neurological，

inflammatory and connective tissue pathways in a

spontaneous model of human small vessel stroke[J].

Neuropathol Appl Neurobiol，2014，40：855-872.

45 Bragulat E，de la Sier ra A，Antonio MT，et al.

Endothelial dysfunction in salt-sensitive essential

hypertension[J]. Hypertension，2001，37：444-448.

46 Ma XJ，Cheng JW，Zhang J，et al. E-select in

deficiency attenuates brain ischemia in mice[J]. CNS

Neurosci Ther，2012，18：903-908.

47 Rouhl RP，Damoiseaux JG，Lodder J，et al. Vascular

inf lammation in cerebral small vessel disease[J].

Neurobiol Aging，2012，33：1800-1806.

140 Chin J Stroke, Feb 2017, Vol 12, No.2

48 Aribisala BS，Wiseman S，Morris Z，et al. Circulating

inflammatory markers are associated with magnetic

resonance imaging-visible perivascular spaces but not

directly with white matter hyperintensities[J]. Stroke，

2014，45：605-607.

49 Abbott NJ. Inflammatory mediators and modulation

of blood-brain barrier permeability[J]. Cell Mol

Neurobiol，2000，20：131-147.

50 Leong XF，Ng CY，Badiah B，et al. Association

between hypertension and periodontitis：possible

mechanisms[J]. Scientific World Journal，2014，2014：

768237.

51 Nakano K，Hokamura K，Taniguchi N，et al. The

collagen-binding protein of Streptococcus mutans

is involved in haemorrhagic stroke[J]. Nat Commun，

2011，2：485.

52 Miya t a n i F，Kur iyama N，Wat anabe I，e t a l .

Relationship between Cnm-positive Streptococcus

mutans and cerebral microbleeds in humans[J]. Oral

Dis，2015，21：886-893.

53 Pussinen PJ，Alfthan G，Jousilahti P，et al. Systemic

exposure to Porphyromonas gingivalis predicts

incident stroke[J]. Atherosclerosis，2007，193：222-

228.

54 Lourbakos A，Yuan YP，Jenkins AL，et al. Activation

of protease-activated receptors by gingipains from

Porphyromonas gingivalis leads to platelet aggregation：

a new trait in microbial pathogenicity[J]. Blood，2001，

97：3790-3797.

55 Wa l t e r C，Za h l t e n J，S c hme c k B，e t a l .

Porphyromonas gingivalis strain-dependent activation

of human endothelial cells[J]. Infect Immun，2004，72：

5910-5918.

56 Ihara M，Yamamoto Y. Emerging evidence for

pathogenesis of sporadic cerebral small vessel

disease[J]. Stroke，2016，47：554-560.

57 Laurent S，Briet M，Boutouyrie P. Large and small

artery cross-talk and recent morbidity-mortality trials

in hypertension[J]. Hypertension，2009，54：388-392.

58 S c u t e r i A，Ni l s son PM，Tz o u r io C，e t a l .

Mic rovascular brain damage with aging and

hypertension：pathophysiological consideration and

clinical implications[J]. J Hypertens，2011，29：1469-

1477.

59 Bink DI，Ritz K，Aronica E，et al. Mouse models to

study the effect of cardiovascular risk factors on brain

structure and cognition[J]. J Cereb Blood Flow Metab，

2013，33：1666-1684.

60 Hol land PR，Searcy JL，Salvadores N，et a l.

Gliovascular disruption and cognitive deficits in a

mouse model with features of small vessel disease[J].

J Cereb Blood Flow Metab，2015，35：1005-1014.

61 Nakaji K，Ihara M，Takahashi C，et al. Matrix

metalloproteinase-2 plays a critical role in the

pathogenesis of white matter lesions after chronic

cerebral hypoperfusion in rodents[J]. Stroke，2006，37：

2816-2823.

62 Hat tor i Y，Okamoto Y，Maki T，et al. Si lent

information regulator 2 homolog 1 counters cerebral

hypoperfusion injury by deacetylating endothelial

nitric oxide synthase[J]. Stroke，2014，45：3403-3411.

63 F e n g S ，C e n J，Hu a n g Y，e t a l . M a t r i x

metalloproteinase-2 and -9 secreted by leukemic cells

increase the permeability of blood-brain barrier by

disrupting tight junction proteins[J]. PLoS One，2011，

6：e20599.

64 Bailey EL，Smith C，Sudlow CL，et al. Is the

spontaneously hyper tensive stroke prone rat a

pertinent model of sub cortical ischemic stroke? A

systematic review[J]. Int J Stroke，2011，6：434-444.

65 Corbin ZA，Rost NS，Lorenzano S，et al. White

matter hyperintensity volume correlates with matrix

metalloproteinase-2 in acute ischemic stroke[J]. J

Stroke Cerebrovasc Dis，2014，23：1300-1306.

66 Ihara M，Tomimoto H. Lessons f rom a mouse

model characterizing features of vascular cognitive

impairment with white matter changes[J]. J Aging Res，

2011，2011：978 761.

67 Armulik A，Abramsson A，Betsholtz C. Endothelial/

pericyte interactions[J]. Circ Res，2005，97：512-523.

68 Craggs LJ，Yamamoto Y，Ihara M，et al. White

matter pathology and disconnection in the frontal

lobe in cerebral autosomal dominant arteriopathy

with subcortical infarcts and leukoencephalopathy

(CADASIL)[J]. Neuropathol Appl Neurobiol，2014，40：

591-602.

69 Cr aggs L J，Fe nwi ck R，Oa k ley AE，e t a l .

Immunolocalization of platelet-derived growth factor

receptor-β (PDGFR-β) and pericytes in cerebral

autosomal dominant arteriopathy with subcortical

infarcts and leukoencephalopathy (CADASIL)[J].

Neuropathol Appl Neurobiol，2015，41：557-570.

70 Bell RD，Winkler EA，Sagare AP，et al. Pericytes

control key neurovascular functions and neuronal

phenotype in the adult brain and during brain aging[J].

Neuron，2010，68：409-427.

71 Miyamoto N，Maki T，Shindo A，et al. Astrocytes

promote oligodendrogenesis after white matter

damage via brain-derived neurotrophic factor[J]. J

Neurosci，2015，35：14 002-14 008.

中国卒中杂志 2017年２月 第12卷 第２期 141

72 Abbott NJ，Rönnbäck L，Hansson E. Astrocyteendothelial

interactions at the blood-brain barrier[J].

Nat Rev Neurosci，2006，7：41-53.

73 Maki T，Maeda M，Uemura M，et al. Potential

interactions between pericytes and oligodendrocyte

precursor cells in perivascular regions of cerebral

white matter[J]. Neurosci Lett，2015，597：164-169.

74 Nakane H，Ibayashi S，Fujii K，et al. Cerebral blood

f low and metabolism in patients with silent brain

infarction：occult misery perfusion in the cerebral

cortex[J]. J Neurol Neurosurg Psychiatry，1998，65：

317-321.

75 Markus HS，Lythgoe DJ，Ostegaard L，et al. Reduced

cerebral blood f low in white matter in ischaemic

leukoaraiosis demonst rated using quantitative

exogenous contrast based perfusion MRI[J]. J Neurol

Neurosurg Psychiatry，2000，69：48-53.

76 Fu JH，Lu CZ，Hong Z，et al. Relationship between

cerebral vasomotor reactivity and white matter lesions

in elderly subjects without large artery occlusive

disease[J]. J Neuroimaging，2006，16：120-125.

77 Shibata M，Ohtani R，Ihara M，et al. White matter

lesions and glial activation in a novel mouse model of

chronic cerebral hypoperfusion[J]. Stroke，2004，35：

2598-2603.

78 Ba ck SA，Han BH，Luo NL，et al. Select ive

vulnerability of late oligodendrocyte progenitors to

hypoxia-ischemia[J]. J Neurosci，2002，22：455-463.

79 Smith EE，Greenberg SM. Beta-amyloid，blood

vessels，and brain function[J]. Stroke，2009，40：

2601-2606.

80 Vinters HV. Cerebral amyloid angiopathy. A critical

review[J]. Stroke，1987，18：311-324.

81 Vonsattel JP，Myers RH，Hedley-Whyte ET，et

al. Cerebral amyloid angiopathy without and with

cerebral hemorrhages：a comparative histological

study[J]. Ann Neurol，1991，30：637-649.

82 Zekry D，Duyckaerts C，Belmin J，et al. Cerebral

amyloid angiopathy in the elderly：vessel walls

changes and relationship with dementia[J]. Acta

Neuropathol，2003，106：367-373.

83 Smith EE，Gurol ME，Eng JA，et al. White matter

lesions，cognition，and recurrent hemorrhage in lobar

intracerebral hemorrhage[J]. Neurology，2004，63：

1606-1612.

84 Gurol ME，Irizarry MC，Smith EE，et al. Plasma

beta-amyloid and white matter lesions in AD，MCI，

and cerebral amyloid angiopathy[J]. Neurology，2006，

66：23-29.

85 Holland CM，Smith EE，Csapo I，et al. Spatial

distribution of white-matter hyperintensities in

Alzheimer disease，cerebral amyloid angiopathy，and

healthy aging[J]. Stroke，2008，39：1127-1133.

86 Viswanathan A，Patel P，Rahman R，et al. Tissue

microstructural changes are independently associated

with cognitive impairment in cerebral amyloid

angiopathy[J]. Stroke，2008，39：1988-1992.

87 Viswanathan A，Greenberg SM. Cerebral amyloid

angiopathy in the elderly[J]. Ann Neurol，2011，70：

871-880.

88 Kövari E，Charidimou A，Herrmann FR，et al. No

neuropathological evidence for a direct topographical

relation between microbleeds and cerebral amyloid

angiopathy[J]. Acta Neuropathol Commun，2015，3：

49.

89 Br own WR，Moody DM，Cha l la VR，e t a l .

Venous collagenosis and arteriolar tortuosity in

leukoaraiosis[J]. J Neurol Sci，2002，203-204：159-

163.

90 Zhou M，Mao L，Wang Y，et al. Morphologic

changes of cerebral veins in hypertensive rats：venous

collagenosis is associated with hypertension[J]. J

Stroke Cerebrovasc Dis，2015，24：530-536.

91 Moody DM，Brown WR，Cha l la VR，e t a l .

Periventricular venous collagenosis：association with

leukoaraiosis[J]. Radiology，1995，194：469-476.

92 Yan S，Wan J，Zhang X，et al. Increased visibility

of deep medullary veins in leukoaraiosis：a 3-T MRI

study[J]. Front Aging Neurosci，2014，6：144.

93 Pantoni L，Gorelick PB. Cerebral small vessel

disease[M]. Cambridge，United Kingdom：Cambridge

University Press，2014.

94 van Golen LW，Kuijer JP，Huisman MC，et al.

Quantification of cerebral blood f low in healthy

volunteers and type 1 diabetic patients：comparison

of MRI arterial spin labeling and [(15)O]H2O positron

emission tomography (PET)[J]. J Magn Reson

Imaging，2014，40：1300-1309.

95 Feng CM，Narayana S，Lancaster JL，et al. CBF

changes during brain activation：fMRI vs. PET[J].

Neuroimage，2004，22：443-446.

96 Wallin A，Blennow K，Fredman P，et al. Blood brain

barrier function in vascular dementia[J]. Acta Neurol

Scand，1990，81：318-322.

97 Pantoni L，Inzitari D，Pracucci G，et al. Cerebrospinal

fluid proteins in patients with leucoaraiosis：possible

abnormalities in blood-brain barrier function[J]. J

Neurol Sci，1993，115：125-131.

98 Wallin A，Sjögren M，Edman A，et al. Symptoms，

vascular risk factors and blood-brain barrier function

142 Chin J Stroke, Feb 2017, Vol 12, No.2

in relation to CT white-matter changes in dementia[J].

Eur Neurol，2000，44：229-235.

99 Taheri S，Gasparovic C，Shah NJ，et al. Quantitative

measurement of blood-brain barrier permeability

in human using dynamic contrast-enhanced MRI

with fast T1 mapping[J]. Magn Reson Med，2011，65：

1036-1042.

100 Hansson J，Vasan RS，Ärnlöv J，et al. Biomarkers of

extracellular matrix metabolism (MMP-9 and TIMP-

1) and risk of stroke，myocardial infarction，and

cause-specific mortality：cohort study[J]. PLoS One，

2011，6：e16185.

101 G iwa MO，Wi l l iams J，Elde r f ield K，e t a l .

Neuropathologic evidence of endothelial changes in

cerebral small vessel disease[J]. Neurology，2012，78：

167-174.

102 Hu J，wanden Steen PE，Sang QX，et al. Matrix

met al loproteinase inhibitor s a s therapy for

inflammatory and vascular diseases[J]. Nat Rev Drug

Discov，2007，6：480-498.